Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Sarcoma 180 D012510 21 associated lipids
Edema D004487 152 associated lipids
Arthritis D001168 41 associated lipids
Heart Failure D006333 36 associated lipids
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Acne Vulgaris D000152 35 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Melanoma D008545 69 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Proteinuria D011507 30 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Psoriasis D011565 47 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Nerve Degeneration D009410 53 associated lipids
Hypertension D006973 115 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Hyperalgesia D006930 42 associated lipids
Anaphylaxis D000707 35 associated lipids
Thrombocytopenia D013921 15 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Cardiomyopathies D009202 10 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Adenoma D000236 40 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Vascular Diseases D014652 16 associated lipids
Ovarian Diseases D010049 5 associated lipids
Anemia D000740 21 associated lipids
Glioblastoma D005909 27 associated lipids
Fabry Disease D000795 4 associated lipids
Influenza, Human D007251 11 associated lipids
Retinal Detachment D012163 10 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Atherosclerosis D050197 85 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Insulin Resistance D007333 99 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Endotoxemia D019446 27 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Acute Lung Injury D055371 33 associated lipids
Sensation Disorders D012678 2 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Neuralgia D009437 28 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Lung Injury D055370 14 associated lipids
Teratocarcinoma D018243 7 associated lipids
Eye Abnormalities D005124 7 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Ileus D045823 3 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Niemann-Pick Disease, Type C D052556 1 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Dragusin M et al. Effects of sphingosine-1-phosphate and ceramide-1-phosphate on rat intestinal smooth muscle cells: implications for postoperative ileus. 2006 FASEB J. pmid:16877527
Garg SK et al. Does sphingosine 1-phosphate play a protective role in the course of pulmonary tuberculosis? 2006 Clin. Immunol. pmid:17049310
Ahmad M et al. The effect of hypoxia on lipid phosphate receptor and sphingosine kinase expression and mitogen-activated protein kinase signaling in human pulmonary smooth muscle cells. 2006 Prostaglandins Other Lipid Mediat. pmid:16647641
Pan CY et al. Lysophospholipids elevate [Ca2+]i and trigger exocytosis in bovine chromaffin cells. 2006 Neuropharmacology pmid:16616768
Fieber CB et al. Modulation of total Akt kinase by increased expression of a single isoform: requirement of the sphingosine-1-phosphate receptor, Edg3/S1P3, for the VEGF-dependent expression of Akt3 in primary endothelial cells. 2006 Exp. Cell Res. pmid:16527273
Berdyshev EV et al. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells. 2006 Cell. Signal. pmid:16529909
Xu SZ et al. A sphingosine-1-phosphate-activated calcium channel controlling vascular smooth muscle cell motility. 2006 Circ. Res. pmid:16675717
Jiang X and Han X Characterization and direct quantitation of sphingoid base-1-phosphates from lipid extracts: a shotgun lipidomics approach. 2006 J. Lipid Res. pmid:16682747
Olivera A et al. IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. 2006 J. Biol. Chem. pmid:16316995
Dahm F et al. Distribution and dynamic changes of sphingolipids in blood in response to platelet activation. 2006 J. Thromb. Haemost. pmid:17010150
Rahaman M et al. Neutrophil sphingosine 1-phosphate and lysophosphatidic acid receptors in pneumonia. 2006 Am. J. Respir. Cell Mol. Biol. pmid:16224106
Squecco R et al. Sphingosine 1-phosphate induces myoblast differentiation through Cx43 protein expression: a role for a gap junction-dependent and -independent function. 2006 Mol. Biol. Cell pmid:16957055
Whetzel AM et al. Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor. 2006 Circ. Res. pmid:16960101
von Wenckstern H et al. The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology. 2006 Jul-Aug Arch. Immunol. Ther. Exp. (Warsz.) pmid:16830220
Pan CY et al. Lysophospholipids regulate excitability and exocytosis in cultured bovine chromaffin cells. 2007 J. Neurochem. pmid:17630986
Shimizu T et al. Sphingosine 1-phosphate receptor 2 negatively regulates neointimal formation in mouse arteries. 2007 Circ. Res. pmid:17872461
Kunisawa J et al. Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epithelium. 2007 J. Exp. Med. pmid:17875673
Klingenberg R et al. Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice. 2007 Arterioscler. Thromb. Vasc. Biol. pmid:17761943
Argraves KM and Argraves WS HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects. 2007 J. Lipid Res. pmid:17698855
Hanessian S et al. Constrained azacyclic analogues of the immunomodulatory agent FTY720 as molecular probes for sphingosine 1-phosphate receptors. 2007 Bioorg. Med. Chem. Lett. pmid:17070046
Smicun Y et al. S1P and LPA have an attachment-dependent regulatory effect on invasion of epithelial ovarian cancer cells. 2007 Gynecol. Oncol. pmid:17716713
Deng Q et al. Identification of Leu276 of the S1P1 receptor and Phe263 of the S1P3 receptor in interaction with receptor specific agonists by molecular modeling, site-directed mutagenesis, and affinity studies. 2007 Mol. Pharmacol. pmid:17170199
Braun A et al. Paucity of pericytes in germinal matrix vasculature of premature infants. 2007 J. Neurosci. pmid:17978043
Hinson JS et al. Smooth muscle cell-specific transcription is regulated by nuclear localization of the myocardin-related transcription factors. 2007 Am. J. Physiol. Heart Circ. Physiol. pmid:16997888
Van Brocklyn JR Sphingolipid signaling pathways as potential therapeutic targets in gliomas. 2007 Mini Rev Med Chem pmid:17979800
Walzer T et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. 2007 Nat. Immunol. pmid:17965716
Sato K et al. Critical role of ABCA1 transporter in sphingosine 1-phosphate release from astrocytes. 2007 J. Neurochem. pmid:17931360
Michel MC et al. Vascular effects of sphingolipids. 2007 Acta Paediatr Suppl pmid:17391441
Goetzl EJ et al. Sphingosine 1-phosphate as an intracellular messenger and extracellular mediator in immunity. 2007 Acta Paediatr Suppl pmid:17391442
Peters SL and Alewijnse AE Sphingosine-1-phosphate signaling in the cardiovascular system. 2007 Curr Opin Pharmacol pmid:17280869
Tellier E et al. Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway. 2007 Mol. Cell. Biol. pmid:17283058
Jiang LI et al. Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway. 2007 J. Biol. Chem. pmid:17283075
Cai Q et al. Validation of fumonisin biomarkers in F344 rats. 2007 Toxicol. Appl. Pharmacol. pmid:17904604
Kono M et al. Deafness and stria vascularis defects in S1P2 receptor-null mice. 2007 J. Biol. Chem. pmid:17284444
Herr DR et al. Sphingosine 1-phosphate (S1P) signaling is required for maintenance of hair cells mainly via activation of S1P2. 2007 J. Neurosci. pmid:17287522
Pappu R et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. 2007 Science pmid:17363629
Zabielski P et al. Partial hepatectomy activates production of the pro-mitotic intermediates of the sphingomyelin signal transduction pathway in the rat liver. 2007 Prostaglandins Other Lipid Mediat. pmid:17499747
Olivera A et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. 2007 Immunity pmid:17346996
Catarzi S et al. Sphingosine 1-phosphate stimulation of NADPH oxidase activity: relationship with platelet-derived growth factor receptor and c-Src kinase. 2007 Biochim. Biophys. Acta pmid:17349748
Park KS et al. S1P stimulates chemotactic migration and invasion in OVCAR3 ovarian cancer cells. 2007 Biochem. Biophys. Res. Commun. pmid:17349972
Togame H et al. Development of a simple and robust assay to screen for inhibitors of sphingosine kinases. 2007 Assay Drug Dev Technol pmid:17477830
Pilorget A et al. Modulation of P-glycoprotein function by sphingosine kinase-1 in brain endothelial cells. 2007 J. Neurochem. pmid:17316399
Hudson NK et al. Modulation of human arterial tone during pregnancy: the effect of the bioactive metabolite sphingosine-1-phosphate. 2007 Biol. Reprod. pmid:17409372
Itagaki K et al. Sphingosine 1-phosphate has dual functions in the regulation of endothelial cell permeability and Ca2+ metabolism. 2007 J. Pharmacol. Exp. Ther. pmid:17626797
Murph M and Mills GB Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression. 2007 Expert Rev Mol Med pmid:17935635
Lee YM et al. A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC). 2007 Prostaglandins Other Lipid Mediat. pmid:17991617
Tani M et al. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. 2007 Cell. Signal. pmid:16963225
Wong RC et al. Anti-apoptotic effect of sphingosine-1-phosphate and platelet-derived growth factor in human embryonic stem cells. 2007 Stem Cells Dev. pmid:18047416
Herzinger T et al. Sphingosine-1-phosphate signaling and the skin. 2007 Am J Clin Dermatol pmid:18039015
Furukawa A et al. Production of nerve growth factor enhanced in cultured mouse astrocytes by glycerophospholipids, sphingolipids, and their related compounds. 2007 Mol. Cell. Biochem. pmid:17577630